mutLBSgeneDB |
Gene summary for IDI2 |
![]() |
Basic gene Info. | Gene symbol | IDI2 |
Gene name | isopentenyl-diphosphate delta isomerase 2 | |
Synonyms | IPPI2 | |
Cytomap | UCSC genome browser: 10p15.3 | |
Type of gene | protein-coding | |
RefGenes | NM_033261.2, | |
Description | IPP isomerase 2diphosphate dimethylallyl diphosphate isomerase 2isopentenyl pyrophosphate isomerase 2isopentenyl-diphosphate Delta-isomerase 2isopentenyl-diphosphate delta-isomerase 2 | |
Modification date | 20141207 | |
dbXrefs | MIM : 615389 | |
HGNC : HGNC | ||
Ensembl : ENSG00000148377 | ||
HPRD : 17127 | ||
Vega : OTTHUMG00000017537 | ||
Protein | UniProt: Q9BXS1 go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_IDI2 | |
BioGPS: 91734 | ||
Pathway | NCI Pathway Interaction Database: IDI2 | |
KEGG: IDI2 | ||
REACTOME: IDI2 | ||
Pathway Commons: IDI2 | ||
Context | iHOP: IDI2 | |
ligand binding site mutation search in PubMed: IDI2 | ||
UCL Cancer Institute: IDI2 | ||
Assigned class in mutLBSgeneDB | C: This gene just belongs to mutLBSgenes. |
![]() |
GO ID | GO Term | PubMed ID | GO:0008299 | isoprenoid biosynthetic process | 17202134 | GO:0046490 | isopentenyl diphosphate metabolic process | 17202134 |
Top |
Ligand binding site mutations for IDI2 |
![]() We represented ligand binding site mutations only. (You can see big image via clicking.) ![]() |
![]() |
![]() |
LBS | AAchange of nsSNV | Cancer type | # samples | R111 | R111H | COAD | 1 | E146 | E146Q | LUSC | 1 | E115,R111 | Q113P | OV | 1 | R111 | R111H | STAD | 1 |
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma. |
Top |
Protein structure related information for IDI2 |
![]() Mupro score denotes assessment of the effect of mutations on thermodynamic stability. (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability) |
![]() ![]() |
![]() |
![]() Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene. |
LBS | AAchange of nsSNV | Relative stability change | E146 | E146Q | -1.3116762 | R111 | R111H | -0.58740698 | E115 | Q113P | -0.094361606 | R111 | Q113P | -0.094361606 |
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132) |
![]() |
Top |
Differential gene expression and gene-gene network for IDI2 |
![]() |
![]() |
Top |
Top |
Phenotype information for IDI2 |
![]() |
Disease ID | Disease name | # PubMed | Association type |
![]() |
Allele ID | AA change | Clinical significance | Origin | Phenotype IDs |
Top |
Pharmacological information for IDI2 |
![]() |
Drug status | DrugBank ID | Name | Type | Drug structure |
![]() |
![]() |
![]() |
Ligand ID | Ligand short name | Ligand long name | PDB ID | PDB name | mutLBS | CA | CALCIUM(2+) | 2pny | A | E115 | MN | MANGANESE(2+) | 2pny | A | E146 | POP | DIPHOSPHATE(2-) | 2pny | A | R111 E115 |
Top |
Conservation information for LBS of IDI2 |
![]() |
LBS | AA sequence | # species | Species |
![]() |
Copyright © 2016-Present - The University of Texas Health Science Center at Houston |